Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-28.00	8.99	12.48
Graham Fair Price	41.42	10.14	7.17
PEG	-24.48	0.01	-0.02
Price/Book	-8.31	0.30	0.32
Price/Cash Flow	-54.15	12.15	26.49
Prices/Earnings	-54.15	1.40	3.06
Price/Sales	-57.38	7.94	18.62
Price/FCF	-54.15	12.15	26.49
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-29.54	0.70	1.00
Operating Margin	5.48	0.59	0.55
ROA	100.00	0.03	0.01
ROE	0.03	0.05	100.00
ROIC	< 0.005	0.02	127.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-0.74
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.56	1.27	128.53
EPS QOQ	1.58	0.96	-39.29
FCF QOQ	-0.18	1.00	460.77
Revenue QOQ	-0.53	1.15	118.93
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	1444.10	100.00
Days Sales Outstanding (DSO)	0.00	66.26	100.00
Inventory Turnover	0.00	0.06	100.00
Debt/Capitalization	0.04	0.04	-0.71
Quick Ratio	413.04	3.05	-99.26
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	9.30	9.30	< 0.005
Cash	1.31	1.31	< 0.005
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	0.11	0.23	100.00
Revenue	0.16	0.35	115.17
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	413.04	3.15	-99.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.20	-4.26	17.97
Naive Interpretation	Member

06 - Financial Health · Bad

Rating